Metrics Master Income Trust (MXT) ORDINARY UNITS FULLY PAID |
Financials |
$2,505 |
Dividend/Distribution - MXT
|
25 Jul 2024 9:25AM |
$2.080 |
$2.050 |
fallen by
1.44%
|
|
Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$22 |
Proposed issue of securities - OSL
|
25 Jul 2024 9:25AM |
$0.009 |
$1.180 |
risen by
13,011.11%
|
|
Metrics Income Opportunities Trust (MOT) ORDINARY UNITS FULLY PAID |
Financials |
$686 |
Dividend/Distribution - MOT
|
25 Jul 2024 9:23AM |
$2.210 |
$2.060 |
fallen by
6.79%
|
|
Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$35 |
Investor Presentation
|
25 Jul 2024 9:23AM |
$0.100 |
$0.115 |
risen by
15%
|
|
Javelin Minerals Limited (JAV) ORDINARY FULLY PAID |
Materials |
$13 |
Capital Raisings Completed
|
25 Jul 2024 9:22AM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$15 |
Trading Halt
|
25 Jul 2024 9:22AM |
$0.029 |
$0.039 |
risen by
34.48%
|
|
KAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Kalgoorlie Gold Mining Limited (ASX: KAL) has requested a trading halt.
- The trading halt is pending the release of a Mineral Resource Estimate and consideration of capital raising.
- The trading halt is to remain until the announcement is made or commencement of normal trading on 29 July 2024.
- The request for the trading halt was made to prepare necessary market announcements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Carnegie Clean Energy Limited (CCE) ORDINARY FULLY PAID |
Utilities |
$20 |
Notification regarding unquoted securities - CCE
|
25 Jul 2024 9:22AM |
$0.044 |
$0.055 |
risen by
25%
|
|
Next Science Limited (NXS) ORDINARY FULLY PAID |
Health Care |
$41 |
Application for quotation of securities - NXS
|
25 Jul 2024 9:20AM |
$0.300 |
$0.140 |
fallen by
53.33%
|
|
Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$22 |
Australian institution to invest $2.7 million in OSL
|
25 Jul 2024 9:19AM |
$0.009 |
$1.180 |
risen by
13,011.11%
|
|
OSL - Price-sensitive ASX Announcement
Full Release
Key Points
- OncoSil Medical Limited secures $2.7 million investment
- Investment from an Australian institutional investor
- Issue price of $0.007 per new share
- Funds to support the OncoSilâ„¢ device commercialisation and accreditation
- Enhancement of distribution network and clinical trials
- New shares trading from 31 July 2024
- Forrest Capital Pty Ltd and McFarlane Cameron Pty Ltd as Joint Lead Managers
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Adisyn Ltd (AI1) ORDINARY FULLY PAID |
Information Technology |
$53 |
Trading Halt
|
25 Jul 2024 9:18AM |
$0.038 |
$0.073 |
risen by
92.11%
|
|
AI1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Adisyn Ltd (ASX: AI1) requested a trading halt.
- The trading halt was requested pending the release of an announcement regarding a proposed capital raise.
- The trading halt commenced on 25 July 2024.
- The securities will remain in trading halt until the earlier of the commencement of normal trading on 29 July 2024 or the release of the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Pacific Smiles Group Limited (PSQ) ORDINARY FULLY PAID |
Health Care |
$266 |
Supplementary disclosure - NDCs best and highest price
|
25 Jul 2024 9:17AM |
$1.820 |
$1.645 |
fallen by
9.62%
|
|
PSQ - Price-sensitive ASX Announcement
Full Release
Key Points
- NDC BidCo has increased the scheme consideration to $1.91 per share.
- NDC BidCo has confirmed this is the best and highest price unless a superior proposal emerges.
- The independent expert continues to find the scheme fair, reasonable, and in the best interests of Pacific Smiles Shareholders.
- The total cash value of $1.91 represents significant premiums over the recent trading prices of Pacific Smiles shares.
- If the scheme does not proceed, the share price may decline and shareholders might continue to be exposed to business risks.
- Some major shareholders, including HBF Health Limited and MA Financial Group Limited, intend to vote in favor of the scheme.
- Genesis Capital has indicated it will vote against the scheme despite the improved proposal.
- The key dates for the scheme include the scheme meeting on August 1, 2024, and the implementation date on August 19, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Aurumin Limited (AUN) ORDINARY FULLY PAID |
Materials |
$55 |
Southern Geoscience Engaged to Model Iron Targets
|
25 Jul 2024 9:17AM |
$0.039 |
$0.110 |
risen by
182.05%
|
|
AUN - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurumin Limited has engaged Southern Geoscience Consultants for modelling geophysical datasets.
- The modelling aims to identify iron ore exploration targets at the Central Sandstone Project.
- Recent rock chip results show potential for high-grade iron ore with peaks of 67% Fe.
- An estimated 6km strike of banded iron outcrops with widths up to 40m needs further exploration.
- Drill testing is expected in the next drilling campaign.
- Results expected by mid-August.
- High-grade iron ore is located near a main sealed road used for hauling DSO iron ore.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$90,222 |
Update on investigations into Australian Markets business
|
25 Jul 2024 9:16AM |
$29.490 |
$30.240 |
risen by
2.54%
|
|
Australian Agricultural Company Limited (AAC) ORDINARY FULLY PAID |
Consumer Staple |
$862 |
Chairman & MD/CEO Addresses to AGM
|
25 Jul 2024 9:15AM |
$1.380 |
$1.430 |
risen by
3.62%
|
|
Sports Entertainment Group Limited (SEG) ORDINARY FULLY PAID |
Communication Services |
$83 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
25 Jul 2024 9:15AM |
$0.300 |
$0.300 |
fallen by
0%
|
|
SEG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations increased by 7% to $31.9 million.
- Net cash inflows for the period were $2.8 million.
- Cash balance as of 30 June 2024 was $10.8 million.
- SEG repaid $4.1 million of debt facility with CBA and brought gross debt to $20 million.
- SEG received a $2.1 million deposit from the staged sale of the Perth Wildcats.
- Operational cash inflows were $5.8 million.
- Issued shares of $1 million as part of a $2.2 million private placement at $0.22 per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Agrimin Limited (AMN) ORDINARY FULLY PAID |
Materials |
$38 |
Appendix 5B Cash Flow Report
|
25 Jul 2024 9:14AM |
$0.215 |
$0.100 |
fallen by
53.49%
|
|
AMN - Price-sensitive ASX Announcement
Full Release
Key Points
- Agrimin Limited reported a net cash outflow of $504,000 from operating activities for the quarter ending June 30, 2024.
- The major cash outflows from operating activities include $430,000 for staff costs and $164,000 for administration and corporate costs.
- Cash inflows include $37,000 from interest received and $53,000 from net GST received.
- Investment activities resulted in a net cash outflow of $1,032,000, primarily due to $1,032,000 spent on exploration and evaluation.
- Agrimin Limited raised $1,235,000 from the issue of equity securities during the quarter, with a net cash inflow from financing activities of $1,102,000 after transaction costs and lease liability repayments.
- The company's cash and cash equivalents at the end of the period were $4,054,000.
- The report was authorized by Agrimin’s CEO and Managing Director, Debbie Morrow, with a compliance statement dated July 25, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Globe Metals & Mining Limited (GBE) ORDINARY FULLY PAID |
Materials |
$19 |
Trading Halt
|
25 Jul 2024 9:14AM |
$0.051 |
$0.028 |
fallen by
45.10%
|
|
GBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Globe Metals & Mining Limited (ASX: GBE) requests a trading halt.
- The trading halt is pending an announcement regarding a material capital raising managed by CPS Capital Group Pty Ltd.
- The halt commenced on Thursday, 25 July 2024.
- The trading halt will remain until either an announcement is made or until the start of normal trading on Monday, 29 July 2024.
- Globe expects the trading halt to end with the announcement of the capital raising outcome.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Agrimin Limited (AMN) ORDINARY FULLY PAID |
Materials |
$38 |
Quarterly Activities Report
|
25 Jul 2024 9:14AM |
$0.215 |
$0.100 |
fallen by
53.49%
|
|
AMN - Price-sensitive ASX Announcement
Full Release
Key Points
- Process testwork for Mackay Potash Project was ongoing with leading equipment vendors.
- Environmental Impact Assessment submitted for Mackay Potash Project.
- Ongoing exploration review in West Arunta region.
- Share Purchase Plan shortfall of $1.1 million completed.
- Mackay Potash Project aims to be world's leading seaborne supplier of SOP fertiliser.
- Agrimin's 40% share in Tali Resources valued at $55 million.
- Strong binding offtake agreements in place for SOP production.
- Project funding and strategic partnerships for Mackay Potash Project are advancing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
EcoGraf Limited (EGR) ORDINARY FULLY PAID |
Materials |
$161 |
Updated Epanko Ore Reserve
|
25 Jul 2024 9:14AM |
$0.105 |
$0.355 |
risen by
238.10%
|
|
EGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Updated Ore Reserve for Epanko Graphite Project.
- Epanko Ore Reserve increased to 14.3Mt at 8.8% TGC for 1.25Mt of graphite.
- 110% increase in Proven Ore Reserves.
- 82% of total Ore Reserves classified as Proven.
- 29% increase in contained graphite from 2017.
- Epanko development potential to expand production from 73,000tpa to 300,000tpa.
- Initial 18-year LOM with possibility of an extension.
- New mine design with 'Oxide Ore first' strategy
- Lower cost operations with 80% of the mining considered 'free dig'.
- Stockpiling of low-grade material to extend operating period to 23 years.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Spenda Limited (SPX) ORDINARY FULLY PAID |
Information Technology |
$28 |
Investor Webinar Presentation
|
25 Jul 2024 9:14AM |
$0.009 |
$0.006 |
fallen by
33.33%
|
|
iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$6 |
Cleansing Notice - Share Placement
|
25 Jul 2024 9:12AM |
$0.072 |
$0.033 |
fallen by
54.17%
|
|
Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$49 |
Q4 FY24 Quarterly Investor Presentation & Webinar
|
25 Jul 2024 9:11AM |
$0.180 |
$0.096 |
fallen by
46.67%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Record sales and revenue growth in Australia
- Q4 FY24 unaudited revenue of $4.81m, up 20.2% QoQ and 113% YoY
- Q4 FY24 Personal Testing & Supplements revenue of $3.95m, up 24.0% QoQ and 208.8% YoY
- Full Year unaudited revenue of $12.09m, up 123.1% YoY
- Therapeutics business includes programs for Inflammatory Bowel Disease, Immuno-Oncology, and Autoimmune Disease
- MAP 315 for Inflammatory Bowel Disease is preparing for Phase 2 trials
- Over 1,835 MetaXplore tests sold during Q4 FY24, up 71% QoQ
- Invivo Clinical sales for Q4 FY24 at $2.21m
- Expansion plans in the UK with MetaXplore product launch scheduled for FY25
- Development of next-generation microbiome therapeutics using an advanced AI/ML approach
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Centuria Capital Group (CNI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,496 |
UBS commits financing to Centuria Bass warehouse facility
|
25 Jul 2024 9:10AM |
$1.695 |
$1.803 |
risen by
6.34%
|
|
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,892 |
Neuren to participate in upcoming US investor conferences
|
25 Jul 2024 9:10AM |
$20.720 |
$15.195 |
fallen by
26.67%
|
|
AdNeo Limited (AD1) ORDINARY FULLY PAID |
Communication Services |
$7 |
Voluntary suspension
|
25 Jul 2024 9:09AM |
$0.006 |
$0.050 |
risen by
733.33%
|
|
AD1 - Price-sensitive ASX Announcement
Full Release
Key Points
- AD1 Holdings Ltd requested a voluntary suspension of its shares from the ASX.
- The suspension is pending the completion of a proposed acquisition and associated capital raising.
- The request was made to manage the company's continuous disclosure obligations.
- The suspension is expected to last until the earlier of normal trading on 29 July 2024 or the announcement of the proposed acquisition.
- The company is not aware of any reasons against the suspension.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.